A NEW IDEA ON JUNO THERAPEUTICS $JUNO
This post was published on ZYX Buy Change Alert. JUNO is developing immunotherapies for lymphomas, leukemias and other cancers. It is an upcoming IPO This is a call to buy in the IPO at the IPO price. To be clear, this is not a call to buy the stock post IPO